Article
The impact of the M184V substitution in HIV-1 reverse transcriptase on treatment response.
HIV medicine - 1 Apr 2002
Miller V, Stark T, Loeliger A E, Lange J M A
Abstract excerpt
The M184V mutation in the HIV-1 reverse transcriptase gene is primarily associated with rapid, high-level lamivudine (3TC) resistance. It has also been observed to arise under selective pressure by abacavir, to which it confers low-level resistance. Although the development of viral drug resistance remains a major concern in antiretroviral therapy, it is known that some immunological and clinical benefit can...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
